| ABL | Acetylbritannilactone |
| AD | Alzheimer’s disease |
| AGO-2 | Argonaute 2 |
| ALS | Amyotrophic lateral sclerosis; |
| ANXA-2 | Annexin-2 |
| Aβ | Beta-amyloid peptide |
| BACE1 | β-site APP cleaving enzyme |
| BACH1 | BTB Domain And CNC Homolog 1 |
| BBB | Blood–brain barrier |
| BDMs | Blood-derived monocytes |
| CAPE | Caffeic acid phenethyl ester |
| CAY10512 | 1-fluoro-2-[2-(4-methoxyphenyl)-ethenyl]-benzene |
| CFH | Complement factor H |
| CLDN-1 | Claudin-1 |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| CXCL10 | C-X-C Motif Chemokine Ligand 10 |
| DGCR8 | DiGeorge Syndrome Critical Region Gene 8 |
| DMF | Dimethylfumarate |
| DOCK-1 | Dedicator of cytokinesis 1 |
| EAE | Experimental autoimmune encephalomyelitis |
| ECF | Extracellular fluid |
| ECM | Extracellular matrix |
| EMVs | Endothelial microvesicles |
| GA | Glatiramer acetate |
| GLGZD | GualouGuizhi decoction |
| H2S | Hydrogen sulfide |
| HIV | Human immunodeficiency virus |
| HNG | Human neuronal–glial |
| HSE | Herpes simplex encephalitis |
| HSV | Herpes simplex virus |
| JHMV | strain of mouse hepatitis virus |
| IFN | Interferon |
| IL | Interleukin |
| IL13Rα1 | Interleukin 13 receptor alpha 1 |
| iNOS | Inducible nitric oxide synthase |
| IRF8 | Interferon regulatory factor 8 |
| IS | Ischemic ictus |
| JAK | Janus tyrosine kinase |
| JEV | Japanese encephalitis virus |
| KO | Knockout |
| LPS | Lipopolysaccharide |
| M1 | Pro-inflammatoryphenotype |
| M2 | Anti-inflammatoryphenotype |
| MDMs | Monocyte-derived macrophages |
| MMP-9 | Matrix metalloproteinase |
| MOG | Myelin-oligodendrocyte glycoprotein |
| MPs | Microparticles |
| MS | Multiple sclerosis |
| MSC | Mesenchymal stem cells |
| NDsEV | Extracellular vesicles derived from |
| NF-κB | Nuclear factor κB |
| NO | Nitric oxide |
| NVU | Neurovascular unit |
| p53 | Tumor protein P53 |
| PBMC | Peripheral blood mononuclear cells |
| PD | Parkinson’s disease |
| PI3K | Phosphoinositide 3-kinase |
| PPMS | Primary progressive multiple sclerosis |
| RA | Rosmarinic acid |
| RISC | RNA-Induced Silencing Complex |
| ROS | Reactive oxygen species |
| RRMS | Relapsing-remitting multiple sclerosis |
| SAMHD1 | Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 |
| SDCBP | Syntenin-1 |
| SHIP1 | SH2 Domain-Containing Inositol 5′-Phosphatase1 |
| SNPs | Single nucleotide polymorphisms |
| SOCS1 | Suppressor of cytokine signaling |
| SPMS | Secondary progressive multiple sclerosis |
| STAT | Signal transducer and activator of transcription |
| p-STAT1 | Phosphorylated-Signal Transducers and Activators of Transcription |
| TBI | Traumatic brain injury |
| TBK-1 | TANK-binding kinase 1 |
| TGF-β | Transforming Growth Factor β |
| TLRs | Toll-like receptors |
| TNF-α | Tumor necrosis factor |
| TRBP | TAR RNA binding protein |
| WNV | West Nile virus |
| WT | Wild-type |
| α-syn | α-synuclein |
| ZIKV | Zika virus |